Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 213

    1.

    Dose-additive carcinogenicity of a defined mixture of "dioxin-like compounds".

    Walker NJ, Crockett PW, Nyska A, Brix AE, Jokinen MP, Sells DM, Hailey JR, Easterling M, Haseman JK, Yin M, Wyde ME, Bucher JR, Portier CJ.

    Environ Health Perspect. 2005 Jan;113(1):43-8.PMID: 15626646 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).

    National Toxicology Program.

    Natl Toxicol Program Tech Rep Ser. 2006 Jan;(520):4-246.PMID: 16628245 [PubMed - indexed for MEDLINE]Related articles

    6.

    NTP Toxicology and Carcinogenesis Studies of 2,3,4,7,8-Pentachlorodibenzofuran (PeCDF) (CAS No. 57117-31-4) in Female Harlan Sprague-Dawley Rats (Gavage Studies).

    National Toxicology Program.

    Natl Toxicol Program Tech Rep Ser. 2006 Sep;(525):1-198.PMID: 17160103 [PubMed - in process]Related articles

    9.

    Relative cancer potencies of selected dioxin-like compounds on a body-burden basis: comparison to current toxic equivalency factors (TEFs).

    Gray MN, Aylward LL, Keenan RE.

    J Toxicol Environ Health A. 2006 May;69(10):907-17.PMID: 16728370 [PubMed - indexed for MEDLINE]Related articles

    10.

    Exocrine pancreatic pathology in female Harlan Sprague-Dawley rats after chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds.

    Nyska A, Jokinen MP, Brix AE, Sells DM, Wyde ME, Orzech D, Haseman JK, Flake G, Walker NJ.

    Environ Health Perspect. 2004 Jun;112(8):903-9.PMID: 15175180 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Comparison of chronic toxicity and carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in 2-year bioassays in female Sprague-Dawley rats.

    Walker NJ, Wyde ME, Fischer LJ, Nyska A, Bucher JR.

    Mol Nutr Food Res. 2006 Oct;50(10):934-44.PMID: 16977594 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Gingival carcinogenicity in female Harlan Sprague-Dawley rats following two-year oral treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds.

    Yoshizawa K, Walker NJ, Jokinen MP, Brix AE, Sells DM, Marsh T, Wyde ME, Orzech D, Haseman JK, Nyska A.

    Toxicol Sci. 2005 Jan;83(1):64-77. Epub 2004 Oct 27. Erratum in: Toxicol Sci. 2005 Feb;83(2):405-6. PMID: 15509667 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Estimated cancer risk of dioxins to humans using a bioassay and physiologically based pharmacokinetic model.

    Maruyama W, Aoki Y.

    Toxicol Appl Pharmacol. 2006 Jul 15;214(2):188-98. Epub 2006 Jan 27.PMID: 16443251 [PubMed - indexed for MEDLINE]Related articles

    14.

    The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds.

    Van den Berg M, Birnbaum LS, Denison M, De Vito M, Farland W, Feeley M, Fiedler H, Hakansson H, Hanberg A, Haws L, Rose M, Safe S, Schrenk D, Tohyama C, Tritscher A, Tuomisto J, Tysklind M, Walker N, Peterson RE.

    Toxicol Sci. 2006 Oct;93(2):223-41. Epub 2006 Jul 7. Review.PMID: 16829543 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.

    Smialowicz RJ, DeVito MJ, Williams WC, Birnbaum LS.

    Toxicol Appl Pharmacol. 2008 Mar 15;227(3):477-84. Epub 2007 Dec 3.PMID: 18190939 [PubMed - indexed for MEDLINE]Related articles

    16.

    Evaluation of toxic equivalency factors for induction of cytochromes P450 CYP1A1 and CYP1A2 enzyme activity by dioxin-like compounds.

    Toyoshiba H, Walker NJ, Bailer AJ, Portier CJ.

    Toxicol Appl Pharmacol. 2004 Jan 15;194(2):156-68.PMID: 14736496 [PubMed - indexed for MEDLINE]Related articles

    18.

    Modeling and assaying dioxin-like biological effects for both dioxin-like and certain non-dioxin-like compounds.

    Wilkes JG, Hass BS, Buzatu DA, Pence LM, Archer JC, Beger RD, Schnackenberg LK, Halbert MK, Jennings L, Kodell RL.

    Toxicol Sci. 2008 Mar;102(1):187-95. Epub 2007 Dec 7.PMID: 18065775 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Reproductive Lesions in Female Harlan Sprague-Dawley Rats Following two-Year Oral Treatment With Dioxin and Dioxin-Like Compounds.

    Yoshizawa K, Brix AE, Sells DM, Jokinen MP, Wyde M, Orzech DP, Kissling GE, Walker NJ, Nyska A.

    Toxicol Pathol. 2009 Oct 20. [Epub ahead of print]PMID: 19843953 [PubMed - as supplied by publisher]Related articles

    20.

    A mixture of dioxins, furans, and non-ortho PCBs based upon consensus toxic equivalency factors produces dioxin-like reproductive effects.

    Hamm JT, Chen CY, Birnbaum LS.

    Toxicol Sci. 2003 Jul;74(1):182-91. Epub 2003 May 2.PMID: 12730615 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data